论文部分内容阅读
Esophageal squamous cell carcinoma is worse malignancy with high incidence and mortality for Chinese.
Entinostat enhance the efficacy of cisplatin to inhibit esophageal squamous cell carcinoma
【摘 要】
：
Esophageal squamous cell carcinoma is worse malignancy with high incidence and mortality for Chinese.
【作 者】
：
【机 构】
：
San Yet-sen University Cancer Center
【出 处】
：
第四届广州国际肿瘤学会议
【发表日期】
：
2015年期
其他文献
DNA microarray-based screening of hub genes and pathways related to pediatric malignant germ cell tu
Objectives: Malignant germ cell tumors(GCT)of childhood are rare and heterogeneous neoplasms thought to arise from primordial germ cells.
会议
INFLUENCE ON MALIGNANT BIOLOGICAL BEHAVIORSOF GLIOMA CELL LINES THROUGH DOWN-REGULATION OF CANCER-TE
会议
The 4th guangzhou International symposium on oncology MiR-34b-3 and miR-449a inhibit malignant progr
Purpose: To investigate the tumor suppressing ability and mechanism of miR-34b/c cluster and miR-449a in nasopharyngeal carcinoma(NPC).
会议
OBJECTIVE: To investigate the expression and clinical significances of tumor antigen MAGE-D 4,OY-TE S-1 and NY-SA R-35 in glioma and evaluate these three an
会议
The conventional strategy for cancer therapy offers limited control of specificity and efficacy,study on the molecular mechanism involved in tumor growth an
会议
The epithelial-mesenchymal transition(EMT)has been shown to induce cancer stem traits.However,pharma-therapeutic approach to simultaneously prevent EMT and
会议
Randomized effects of five platinum-based chemotherapy regimens in the first treatment of advanced N
OBJECTIVE: To observe efficacy and security of five chemotherapeutic schemes including platinum on advanced nonsmall-cell lung cancer.
会议
Efficacy and security of treatment by bevacizumab and platinum-based on chemotherapy on advanced non
Objective: To evaluate efficacy and security of treatment by bevacizumab and platinum on advanced nonsmall-cell lung cancer.
The mechanism of bevacizumab combined with cisplatin interfer the invasion and metastasis of lung ad
Objective: Research on the mechanism of bevacizumab combined with cisplatin inhibits the invasion and metastasis of Lewis lung adenocarcinoma.